-
Mildronate-Derived Lipidoids for Safer mRNA Vaccines
2026-08-12
The 2024 ACS Nano study developed mildronate-derived cationic lipidoids and formulated them into mLNP-69, an mRNA delivery system designed to retain efficient transfection while reducing local inflammation. In prophylactic and therapeutic B16OVA melanoma models, mLNP-69 enabled effective cancer-vaccine delivery, supporting low-dose lipid design as a practical direction for preclinical vaccine development research.
-
Puerarin Activates NO Signaling in Dental Follicle Cells
2026-08-12
The reference study shows that puerarin enhances osteogenic differentiation of rat dental follicle cells alongside increased nitric oxide, cGMP, and osteogenic marker expression. Pharmacological inhibition with L-NMMA weakened these responses, supporting a functional role for NO signaling while leaving important questions about dose, cell specificity, and in vivo periodontal regeneration.
-
EZ Cap™ Cre mRNA (m1Ψ) Workflow Guide
2026-08-11
Build a transient Cre-lox recombination pulse with modified, Cap 1-capped mRNA rather than relying on persistent genetic delivery. This practical guide connects cell-based assay design with emerging extrahepatic delivery systems, including the EVMP platform described in ACS Nano.
-
MIR9 Epigenetic Silencing Drives FGFR1 and CDK6 in ALL
2026-08-11
The reference study links MIR9-family hypermethylation with reduced microRNA expression, activation of FGFR1 and CDK6, and poorer outcomes in acute lymphoblastic leukaemia. Its combination of patient-level methylation analysis, survival modelling, and inhibitor experiments provides a mechanistic framework for biomarker development and pathway-directed research.
-
RITA (NSC 652287): Measure Killing, Not Just Viability
2026-08-10
RITA (NSC 652287) can reveal why a cancer cell assay changes by separating growth inhibition from actual cell killing. This guide applies that framework to p53-focused cancer biology, renal carcinoma research, apoptosis assays, and tumor xenograft interpretation.
-
EZ Cap™ Cre mRNA (m1Ψ): Assay Design Guide
2026-08-09
Learn how EZ Cap™ Cre mRNA (m1Ψ) converts Cre-lox biology into a controllable, transient editing pulse. This guide connects mRNA chemistry, assay controls, and emerging extrahepatic delivery strategies for better experimental decisions.
-
Antiarrhythmic Drugs and Cardiac SK Channels
2026-08-08
The 2017 reference study used automated whole-cell patch clamp to test whether established antiarrhythmic drugs modulate human small-conductance calcium-activated potassium channels. Dofetilide and propafenone inhibited hKCa2.2 and hKCa2.3, whereas the broader drug panel, including dronedarone, showed no clinically compelling inhibition, helping distinguish therapeutic mechanisms from off-target channel activity.
-
Artemisinin, NRF2, and Ferroptosis in Diabetic Cognition
2026-08-07
Wang et al. show that artemisinin improves learning and memory deficits in STZ-induced type 2 diabetes mellitus mice while reducing ferroptosis-related injury in hippocampal CA1 neurons. Pharmacological blockade of NRF2 with ML385 and induction of ferroptosis with erastin weakened these benefits, supporting an NRF2–GPX4 antioxidant mechanism rather than a nonspecific behavioral effect.
-
Instant Clot-Forming Antibacterial Dressings with Tranexamic
2026-08-07
The reference study introduces a bi-layer wound dressing that rapidly achieves hemostasis and antibacterial protection using a combination of tranexamic acid, propolis, and a nitric oxide donor. This work demonstrates significant reductions in bleeding and infection risk, supporting advances in trauma care and translational fibrinolysis research.
-
TAK1-Mediated YAP Stabilization Drives Gastric Cancer Stemne
2026-08-06
This study elucidates how TGFβ-activated kinase 1 (TAK1) stabilizes yes-associated protein (YAP) in gastric cancer stem cells, enhancing their self-renewal and oncogenic potential. The findings reveal a mechanistic link with direct implications for targeting stemness and therapy resistance in gastric cancer.
-
Paclitaxel (Taxol) Workflows: Precision in Cancer Research M
2026-08-06
Paclitaxel (Taxol) stands out as a gold-standard microtubule modulator, enabling advanced cancer modeling and drug response profiling. Discover how optimized protocols and patient-derived assembloid systems deliver translational impact and reproducible insights.
-
AICAR in Energy Metabolism Regulation: Protocols & Innovatio
2026-08-05
AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) enables precise control of AMPK-driven metabolic and inflammation pathways in cellular and animal research. This guide bridges cutting-edge reference findings with hands-on workflows, troubleshooting, and comparative advantages for advanced metabolic disease studies.
-
SARS-CoV-2 N Protein Disrupts GADD34-Mediated Antiviral Immu
2026-08-05
This study reveals how the SARS-CoV-2 nucleocapsid protein impairs host antiviral defenses by antagonizing the GADD34-mediated stress response. The findings clarify a critical viral immune evasion mechanism and suggest new directions for research on innate immunity and GPCR pathway modulators.
-
Bafilomycin A1: Precision V-ATPase Inhibitor for Lysosomal S
2026-08-04
Bafilomycin A1 stands out as a gold-standard V-ATPase inhibitor for dissecting lysosomal function and intracellular pH regulation with nanomolar precision. This guide details hands-on protocols, troubleshooting strategies, and advanced applications, including its role in mitophagy studies driven by recent breakthroughs.
-
AMH-SMAD4 Pathway Disrupts Granulosa Cell Growth in PCOS Rat
2026-08-04
This study uncovers how anti-Müllerian hormone (AMH) impairs ovarian granulosa cell proliferation and promotes apoptosis in a PCOS rat model via upregulation of SMAD4. These mechanistic insights clarify the cellular basis of ovulatory dysfunction in PCOS and provide a foundation for targeted experimental assays investigating granulosa cell viability and apoptosis.